Idiopathic anaphylaxis MB Bilò, M Martini, C Tontini, OE Mohamed, MT Krishna Clinical & Experimental Allergy 49 (7), 942-952, 2019 | 60 | 2019 |
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry L Antonicelli, C Tontini, G Manzotti, L Ronchi, A Vaghi, F Bini, ... Allergy 76 (3), 902, 2021 | 51 | 2021 |
Clinical aspects of hymenoptera venom allergy and venom immunotherapy. MB Bilò, C Tontini, M Martini, A Corsi, S Agolini, L Antonicelli European annals of allergy and clinical immunology 51 (6), 244-258, 2019 | 42 | 2019 |
High adherence to hymenoptera venom subcutaneous immunotherapy over a 5-year follow-up: a real-life experience MB Bilò, E Kamberi, C Tontini, L Marinangeli, M Cognigni, MF Brianzoni, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (2), 327-329. e1, 2016 | 36 | 2016 |
Novel approaches in the inhibition of IgE-induced mast cell reactivity in food allergy C Tontini, S Bulfone-Paus Frontiers in immunology 12, 613461, 2021 | 28 | 2021 |
Forced oscillation technique as method to document and monitor the efficacy of mepolizumab in treating severe eosinophilic asthma. L Antonicelli, C Tontini, A Marchionni, B Lucchetti, MS Garritani, MB Bilò Allergy 75 (2), 2020 | 22 | 2020 |
Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation? C Tontini, L Marinangeli, M Cognigni, MB Bilò, L Antonicelli Annals of Allergy, Asthma & Immunology 115 (2), 147-148, 2015 | 19 | 2015 |
Validation of a self-reported HIV symptoms list: the ISS-HIV symptoms scale R Bucciardini, K Pugliese, D Francisci, A Costantini, E Schiaroli, ... AIDS research and therapy 13, 1-7, 2016 | 12 | 2016 |
Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence A Tonacci, E Nettis, R Asero, O Rossi, C Tontini, S Gangemi Eur Ann Allergy Clin Immunol 52 (3), 100-103, 2020 | 8 | 2020 |
Bacillus Calmette–Guérin-induced human mast cell activation relies on IL-33 priming KM Garcia-Rodriguez, A Goenka, DD Thomson, R Bahri, C Tontini, ... International Journal of Molecular Sciences 23 (14), 7549, 2022 | 6 | 2022 |
Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine? MB Bilò J Investig Allergol Clin Immunol 32 (5), 2022 | 6 | 2022 |
Performance Characteristics of Basophil Activation Tests for Diagnosing Penicillin Allergy: A Meta-Analysis MR Bennett, AG Mathioudakis, J Wu, MMH Chu, C Tontini, I Thomas, ... The Journal of Allergy and Clinical Immunology: In Practice 12 (3), 714-723. e5, 2024 | 5 | 2024 |
Safety of a 2-day ultrarush immunotherapy in vespid allergic patients: Focus on elevated serum tryptase MB Bilò, A Corsi, S Agolini, C Tontini, L Antonicelli Annals of Allergy, Asthma & Immunology 121 (1), 130-132, 2018 | 5 | 2018 |
Use of toll-like receptor (TLR) ligation to characterize human regulatory B-cells subsets MAM Chayé, C Tontini, A Ozir-Fazalalikhan, AL Voskamp, HH Smits Regulatory B Cells: Methods and Protocols, 235-261, 2021 | 3 | 2021 |
Venom immunotherapy in Europe and the United States MB Bilò, M Martini, A Corsi, C Tontini, L Antonicelli Allergo Journal International 29, 29-37, 2020 | 3 | 2020 |
Mast cell versus basophil activation test in allergy: Current status DG Ebo, R Bahri, C Tontini, AL Van Gasse, C Mertens, MM Hagendorens, ... Clinical & Experimental Allergy, 2024 | 2 | 2024 |
IgE sialylation: unravelling a key anaphylactic mediator B Moya, C Tontini, A Santos Authorea Preprints, 2020 | 2 | 2020 |
AB0400 Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life G Pomponio, C Tontini, A Angeletti, D Olivari, D Benfaremo, L Manfredi, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 1189-1189, 2017 | 2 | 2017 |
P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33 B Salcman, R Bahri, PW West, C Tontini, K Affleck, S Bulfone-Paus International Journal of Molecular Sciences 25 (3), 1730, 2024 | 1 | 2024 |
Human Mast Cells Upregulate Cathepsin B, a Novel Marker of Itch in Psoriasis PW West, C Tontini, H Atmoko, O Kiss, T Garner, R Bahri, RB Warren, ... Cells 12 (17), 2177, 2023 | 1 | 2023 |